PMCB Buybacks
12 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–12; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| PharmaCyte Biotech, Inc. | 2026-04-30 | Reported repurchase cash | $0.00 |
| PharmaCyte Biotech, Inc. | 2025-07-31 | Reported repurchase cash | $0.00 |
| PharmaCyte Biotech, Inc. | 2025-04-30 | Reported repurchase cash | $171,543.00 |
| PharmaCyte Biotech, Inc. | 2024-07-31 | Reported repurchase cash | $742,179.00 |
| PharmaCyte Biotech, Inc. | 2024-04-30 | Reported repurchase cash | $1.17M |
| PharmaCyte Biotech, Inc. | 2024-01-31 | Reported repurchase cash | $404,717.00 |
| PharmaCyte Biotech, Inc. | 2023-10-31 | Reported repurchase cash | $164,953.00 |
| PharmaCyte Biotech, Inc. | 2023-07-31 | Reported repurchase cash | $26.46M |
| PharmaCyte Biotech, Inc. | 2023-04-30 | Reported repurchase cash | $4.31M |
| PharmaCyte Biotech, Inc. | 2022-07-31 | Reported repurchase cash | $2.09M |
| PharmaCyte Biotech, Inc. | 2022-04-30 | Reported repurchase cash | $0.00 |
| PharmaCyte Biotech, Inc. | 2021-07-31 | Reported repurchase cash | $0.00 |